← Back to patent-cliff list
CAS 1408282-26-7
Codes：RUCA-021
Application context (from source-drug indications)
前列腺癌芦卡帕利腹膜癌芦卡帕利卵巢上皮癌芦卡帕利输卵管癌芦卡帕利卵巢癌芦卡帕利去势抵抗性前列腺肿瘤芦卡帕利
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 芦卡帕利Rucaparib Camsylate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-(2,2-diethoxyethyl)isoindoline-1,3-dione→2-(1,3-dioxoisoindolin-2-yl)acetaldehyde→methyl 6-fluoro-1H-indole-4-carboxylate→methyl 3-(2-(1,3-dioxoisoindolin-2-yl)ethyl)-6-fluoro-1H-indole-4-carboxylate→RUCA-021→RUCA-022→(4-formylphenyl)boronic acid→4-(8-fluoro-6-oxo-3,4,5,6-tetrahydro-1H-azepino[5,4,3-cd]indol-2-yl)benzaldehyde→(E)-8-fluoro-2-(4-((methylimino)methyl)phenyl)-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications |
|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 8-Fluoro-1,3,4,5-tetrahydro-6H-pyrrolo[4,3,2-ef][2]benzazepin -6- one Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.